Have a feature idea you'd love to see implemented?
Let us know!
TOI Oncology Institute Inc
Price (delayed)
$0.2101
Market cap
$15.87M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.78
Enterprise value
$91.42M
Highlights
Oncology Institute's net income has increased by 27% YoY and by 2.3% QoQ
TOI's revenue is up by 22% year-on-year and by 4.9% since the previous quarter
TOI's equity has dropped by 78% year-on-year and by 47% since the previous quarter
The quick ratio has contracted by 48% YoY and by 24% from the previous quarter
Key stats
What are the main financial stats of TOI
Market
Valuations
Earnings
Shares outstanding
75.56M
Market cap
$15.87M
Enterprise value
$91.42M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.02
Price to sales (P/S)
0.04
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.24
Revenue
$378.93M
Gross profit
$53.74M
Net income
-$55.04M
EBIT
-$50.27M
EBITDA
-$44.11M
Free cash flow
-$37.51M
Per share
Balance sheet
Liquidity
EPS
-$0.78
EPS diluted
-$0.78
Free cash flow per share
-$0.5
Book value per share
$0.21
Revenue per share
$5.02
TBVPS
$2.07
Total assets
$179.18M
Total liabilities
$163.7M
Debt
$122.95M
Equity
$15.48M
Working capital
$69.67M
Debt to equity
7.94
Current ratio
2.49
Quick ratio
2.19
Net debt/EBITDA
-1.71
Margins
Efficiency
Dividend
EBITDA margin
-11.6%
Gross margin
14.2%
Net margin
-14.5%
Operating margin
-16.8%
Return on assets
-28.5%
Return on equity
-154%
Return on invested capital
-23.8%
Return on capital employed
-38%
Return on sales
-13.3%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
TOI stock price
How has the Oncology Institute stock price performed over time
Intraday
1.55%
1 week
-5.74%
1 month
58.93%
1 year
-88.06%
YTD
-89.7%
QTD
-35.73%
Financial performance
How have Oncology Institute's revenue and profit performed over time
Revenue
$378.93M
Gross profit
$53.74M
Operating income
-$63.48M
Net income
-$55.04M
Gross margin
14.2%
Net margin
-14.5%
Oncology Institute's operating margin has increased by 40% YoY and by 4.5% from the previous quarter
The company's net margin rose by 40% YoY and by 7% QoQ
The gross margin has contracted by 28% YoY and by 7% from the previous quarter
Oncology Institute's net income has increased by 27% YoY and by 2.3% QoQ
Growth
What is Oncology Institute's growth rate over time
Valuation
What is Oncology Institute stock price valuation
P/E
N/A
P/B
1.02
P/S
0.04
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.24
The EPS has grown by 6% YoY
The stock's P/B is 92% less than its 5-year quarterly average of 13.3 and 51% less than its last 4 quarters average of 2.1
TOI's equity has dropped by 78% year-on-year and by 47% since the previous quarter
The P/S is 97% less than the 5-year quarterly average of 1.5 and 80% less than the last 4 quarters average of 0.2
TOI's revenue is up by 22% year-on-year and by 4.9% since the previous quarter
Efficiency
How efficient is Oncology Institute business performance
The company's return on equity has shrunk by 93% YoY and by 36% QoQ
The ROS has grown by 40% YoY and by 8% from the previous quarter
The ROA is up by 11% year-on-year but it is down by 2.5% since the previous quarter
The company's return on invested capital rose by 7% YoY but it fell by 4.4% QoQ
Dividends
What is TOI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for TOI.
Financial health
How did Oncology Institute financials performed over time
The total assets is 9% more than the total liabilities
The quick ratio has contracted by 48% YoY and by 24% from the previous quarter
The current ratio has contracted by 47% YoY and by 25% from the previous quarter
The debt to equity has soared by 92% from the previous quarter
TOI's equity has dropped by 78% year-on-year and by 47% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.